| ASSET | MONTH | % RETURN |
|---|---|---|
Frontline (FRO) | December 2014 | 83.21% |
Cytokinetics (CYTK) | December 2014 | 72.26% |
Xenon Pharmaceuticals (XENE) | December 2014 | 51.34% |
Veracyte (VCYT) | December 2014 | 48.62% |
Ocular Therapeutix (OCUL) | December 2014 | 40% |
Varonis Systems (VRNS) | December 2014 | 38.93% |
Enphase Energy (ENPH) | December 2014 | 36.1% |
Chefs Warehouse (CHEF) | December 2014 | 35.13% |
Cirrus Logic (CRUS) | December 2014 | 29.15% |
Arrowhead Pharmaceuticals (ARWR) | December 2014 | 28.13% |
IAMGold (IAG) | December 2014 | 26.76% |
MACOM Technology Solutions (MTSI) | December 2014 | 25.88% |
Seaboard (SEB) | December 2014 | 22.75% |
Sandstorm Gold Ltd N (SAND) | December 2014 | 22.75% |
VSE (VSEC) | December 2014 | 22.45% |
Coeur Mining (CDE) | December 2014 | 21.67% |
Bancorp (TBBK) | December 2014 | 21.54% |
Central Garden & Pet (CENT) | December 2014 | 20.94% |
MAG Silver (MAG) | December 2014 | 20.56% |
First Majestic Silver (AG) | December 2014 | 19.81% |
Perdoceo Education (PRDO) | December 2014 | 19.79% |
Ionis Pharmaceuticals (IONS) | December 2014 | 19.65% |
Axcelis Technologies (ACLS) | December 2014 | 19.07% |
Ringcentral (RNG) | December 2014 | 18.98% |
Globant (GLOB) | December 2014 | 18.78% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
